Drug Shortages and Complying with FDA's 21 CFR 211.110 Guidance.
| Publicado en: | BioPharm International Vol. 38; no. 3; pp. 33 - 35 |
|---|---|
| Autores principales: | , |
| Formato: | pictorial questions and answers Journal Article |
| Publicado: |
MJH Life Sciences
Apr2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184485601&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 184485601 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Apr2025 vid: 38 iid: 3 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 184485601 184485601 184485601 184485601 ppf: 33 ppct: 2 formats: fmt: @attributes: type: P tig: atl: Drug Shortages and Complying with FDA's 21 CFR 211.110 Guidance. aug: au: Schniepp, Susan J. LeBlanc-Rivera, Rona sug: subj: Medication Shortage United States Food and Drug Administration Organizational Compliance Quality Control (Technology) Pharmaceutical Companies Feedback Manufacturing Industry Documentation Quality Improvement Organizational Efficiency Drug Approval pubtype: Trade Publication doctype: pictorial questions and answers Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|